Accessibility Tools
Category : Pediatric Orthopedics / Orthopaedics

The FDA cleared an investigational new drug application for NVD-003, a stem cell therapy for treatment of children with congenital pseudarthrosis of the tibia, according to the agent s manufacturer.
Source : Healio
On : 26-Mar-2021